Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02478710 · ClinicalTrials.gov registry record · Phase 4
Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia
A Phase 4 study, sponsored by Wright State University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT02478710: Clinical Trial Phase 4 study, sponsored by Wright State University.
NCT02478710 is a Phase 4 study that was terminated before completion, run by Wright State University. The registered enrollment target is 16 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02478710, a Phase 4 study, was terminated before completion, sponsored by Wright State University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if administering inhaled antibiotics directly into the lungs in conjunction with intravenous (IV) antibiotics leads to better outcomes and decreased recurrence of ventilator associated pneumonia (VAP) when compared to IV antibiotics alone.
Primary Outcome
Recurrence after a second bronchoalveolar lavage (BAL) reveals at least one bacterial species growing at concentrations of greater than 10 to the fourth power organisms during the time period of 9-21 days after initiating therapy.
Interventions
- DRUG Aerosolized Placebo
- DRUG Aerosolized Tobramycin or Vancomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-06 |
| Est. Completion | 2022-07 |
| Phase | Phase 4 |
Why NCT02478710 stopped before completion
NCT02478710 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Aerosolized Placebo is the first listed.
NCT02478710 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02478710 about?
NCT02478710 is a clinical study titled "Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia". The purpose of this study is to determine if administering inhaled antibiotics directly into the lungs in conjunction with intravenous (IV) antibiotics leads to better outcomes and decreased recurrence of ventilator associated pneumonia (VAP) when compared to IV antibiotics alone.
What is the current status of trial NCT02478710?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2015-06. Estimated completion is 2022-07.
What interventions are being tested in trial NCT02478710?
The interventions under investigation include: Aerosolized Placebo (DRUG), Aerosolized Tobramycin or Vancomycin (DRUG).
Who is sponsoring clinical trial NCT02478710?
This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02478710's enrollment target sits among peer trials
16 1869th of 2000 higher than 121 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia